10-K: WLAC Details Boost Run Merger, Faces Going Concern Doubt

Willow Lane Acquisition Corp. filed its 2025 10-K, detailing its proposed merger with Boost Run, reporting a net income of $3.44 million, and acknowledging substantial doubt about its ability to continue as a going concern.

Summary

• Willow Lane Acquisition Corp. (WLAC) is a blank check company incorporated on July 3, 2024, formed for the purpose of effecting a Business Combination.
• The company consummated its Initial Public Offering (IPO) on November 12, 2024, raising $126.5 million from 12,650,000 units at $10.00 per unit.
• Simultaneously with the IPO, a private placement of 5,145,722 warrants generated gross proceeds of $5.15 million.
• A total of $126,879,500 from the IPO and private placement proceeds was placed in a Trust Account.
• WLAC entered into a Business Combination Agreement (BCA) with Boost Run Holdings, LLC on September 15, 2025.
• The Boost Run BCA was amended on January 13, 2026, extending the 'Outside Date' for the Business Combination to June 30, 2026, and removing the covenant for a majority of independent directors on the post-closing Pubco board.
• Upon closing, Pubco (Boost Run Inc.) will become a publicly traded company, with Willow Lane and Boost Run as its wholly-owned subsidiaries.
• Consideration for Boost Run sellers includes an $8.5 million installment note to Andrew Karos (Boost Run's CEO), 44,150,000 newly issued shares of Pubco Common Stock, and 7,875,000 price-based earnout shares for Mr. Karos.
• For the year ended December 31, 2025, WLAC reported a net income of $3,438,450, primarily driven by $5,420,400 in interest earned on investments held in the Trust Account.
• As of December 31, 2025, the company had $322,830 in cash held outside the Trust Account and $132,583,821 in investments within the Trust Account.
• Management has determined that there is substantial doubt about the company's ability to continue as a going concern due to liquidity needs and the November 12, 2026, deadline to complete a Business Combination.
• The deferred underwriting fee of up to $4,427,500 was amended on October 17, 2025, with components tied to IPO proceeds and funds remaining after redemptions.
• Craig-Hallum agreed to reduce its portion of the Deferred Fee by $500,000 in exchange for a right of participation in future Pubco financings.
• B. Luke Weil, WLAC's CEO, will provide consulting services to Pubco post-closing and will be granted 336,000 shares of Pubco Class A Common Stock, subject to price-based vesting.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing with caution due to the explicit 'going concern' doubt, the extension of the merger deadline, and the mixed track record of management's prior SPAC ventures, despite the reported net income from trust account interest.

Positives

• Successfully identified a target business, Boost Run, and entered into a Business Combination Agreement.
• Reported a net income of $3,438,450 for the year ended December 31, 2025, primarily from interest income on the Trust Account.
• The management team has an extensive track record, having successfully identified and closed five prior SPAC Business Combinations.
• The Trust Account holds a substantial amount of $132,583,821 as of December 31, 2025, providing capital for the Business Combination.

Negatives

• Management has identified 'substantial doubt about our ability to continue as a going concern' due to liquidity needs and the approaching Business Combination deadline.
• The company's liquidity outside the Trust Account is limited, with only $322,830 in cash as of December 31, 2025.
• The deadline for completing an initial Business Combination is November 12, 2026, with a risk of liquidation if not met.
• The Boost Run BCA Amendment extended the 'Outside Date' for the Business Combination to June 30, 2026, indicating potential delays or challenges in closing the deal.
• The removal of the covenant requiring a majority of independent directors on the post-closing Pubco board could be perceived as a weakening of corporate governance.
• Public shareholders may experience significant dilution due to the anti-dilution rights of Founder Shares and the exercise of Private Placement Warrants.
• The company will incur a deferred underwriting fee of up to $4,427,500 upon completion of the Business Combination.

Risks

• Inability to complete the initial Business Combination, including the Boost Run Business Combination, within the Combination Period (by November 12, 2026), which would lead to liquidation and worthless warrants.
• Inability to obtain additional financing required to complete the initial Business Combination or fund the operations and growth of Boost Run.
• Issuance of Ordinary Shares to investors in connection with the initial Business Combination at a price less than the prevailing market price, leading to dilution.
• Increased competition for attractive SPAC targets, potentially increasing acquisition costs or preventing a Business Combination.
• Potential conflicts of interest for underwriters due to deferred fees tied to Business Combination completion.
• Risk of acquiring a private company (Boost Run) with limited available information, which may prove to be less profitable than anticipated.
• Resources could be wasted on researching Business Combination targets that are not completed.
• Recent fluctuations in inflation and interest rates, and global geopolitical conditions, could make it more difficult to consummate a Business Combination.
• Changes in laws or regulations, including the U.S. federal 1% excise tax on stock repurchases, may adversely affect the business.
• Risk of being deemed an investment company under the Investment Company Act, leading to burdensome compliance requirements and restricted activities.
• The Sponsor and Management Team have agreed to vote in favor of the initial Business Combination, potentially overriding public shareholder dissent.
• Public shareholders' ability to redeem shares may make the company unattractive to potential targets or dilute the investment of non-redeeming shareholders.
• Lack of business diversification post-Business Combination, making the company dependent on a single business.
• Limited ability to assess the management team of a prospective target business.
• Potential for significant write-downs, write-offs, restructuring, or impairment charges after the Business Combination.
• Tax implications for shareholders and warrant holders due to reincorporation or foreign operations.
• Conflicts of interest arising from officers and directors allocating time to other businesses.
• The value of Founder Shares is likely to be substantially higher than their nominal purchase price, even if public shares decline post-merger.
• Risk of Nasdaq delisting if the company fails to meet listing requirements.
• Shareholders may face difficulties protecting their interests due to the company's Cayman Islands incorporation.
• The terms of Public Warrants may be amended adversely to holders with the approval of 50% of outstanding warrants.
• Warrant holders may only be able to exercise on a cashless basis under certain circumstances, receiving fewer shares.
• Class A Ordinary Shareholders do not have voting rights on director appointments or reincorporation prior to the Business Combination.
• The company's status as a 'controlled company' under Nasdaq rules may lead to exemptions from certain corporate governance requirements.

Future Outlook

The company intends to complete its initial Business Combination with Boost Run by the extended deadline of June 30, 2026, or by the ultimate Combination Period end of November 12, 2026. It anticipates incurring increased expenses as a public company and does not expect to generate operating revenues until after the Business Combination is completed. The post-combination entity, Pubco, aims to leverage its public company status for broader access to capital and to support growth strategies.

Management Comments

• "Our Management Team has an extensive track record of acquiring attractive assets at disciplined valuations, investing in growth while fostering financial discipline and improving business results."
• "We believe that the experience and capabilities of our Management Team makes us an attractive partner to potential target businesses, will enhance our ability to complete a successful Business Combination, and will bring value to the business post-Business Combination."
• "Management plans to consummate an initial Business Combination prior to the end of the Combination Period."

Industry Context

StockSavvy.ai notes that Willow Lane Acquisition Corp. operates in a challenging SPAC environment, where many target businesses have historically underperformed post-Business Combination. The company's reliance on its management team's prior SPAC experience, which includes both successful outcomes like Tecnoglass and significant underperformances or dissolutions like Lazydays and Stryve Foods, highlights the inherent risks and varying results within the SPAC market. The extension of the merger deadline and the removal of the independent board covenant for Boost Run reflect the evolving dynamics and pressures within the SPAC industry, where SPACs often face difficulties in closing deals and adapting governance structures.

Comparison to Industry Standards

• The management team has participated in and consummated 5 prior SPAC Business Combinations, indicating significant experience in the sector.
• Andina I's target, Tecnoglass S.A., saw its common stock price range from $2.29 to $90.34, closing at $52.62 on February 18, 2026, demonstrating a successful outcome.
• Andina II's target, Lazydays R.V. Center, Inc., was dissolved in November 2025, indicating a complete failure.
• Andina III's target, Stryve Foods, LLC, saw its common stock price range from $0.003 to $139.49 (reverse-split adjusted), closing at $0.003 on February 18, 2026, representing significant underperformance.
• Hydra Industries' target, Inspired Gaming Group, saw its common stock price range from $1.90 to $16.44, closing at $8.38 on February 18, 2026, indicating moderate performance.
• Leisure Acquisition's target, Ensysce Biosciences, Inc., saw its common stock price range from $0.24 to $3,480.14 (reverse-split adjusted), closing at $0.3894 on February 18, 2026, also indicating significant underperformance.
• The company explicitly acknowledges that 'in recent years, the stock prices of many target businesses have underperformed post-Business Combination with a SPAC,' aligning with broader industry trends of post-merger struggles for SPAC targets.

Management Changes

Corporate Governance

Legal Proceedings

• To the knowledge of management, there is no material litigation currently pending or contemplated against the company, its officers, or directors in their capacity as such, or against any of its property.

Related Party Transactions

• The Sponsor purchased 4,628,674 Founder Shares for an aggregate of $25,000 (approximately $0.005 per share).
• The Sponsor, BTIG, and Craig-Hallum purchased an aggregate of 5,145,722 Private Placement Warrants at $1.00 per warrant.
• An affiliate of the Sponsor is reimbursed $10,000 per month for office space, utilities, and secretarial and administrative support.
• The Sponsor loaned the company up to $300,000 under an IPO Promissory Note, which was fully repaid ($103,576) by November 18, 2024.
• The Sponsor or its affiliates may provide Working Capital Loans (up to $1,500,000 convertible into warrants) to finance transaction costs, with no such loans outstanding as of December 31, 2025.
• The Sponsor and the company's officers and directors have waived their redemption rights with respect to Founder Shares and certain liquidating distributions from the Trust Account.
• The Earnout Agreement Amendment allows the Sponsor and Goodrich ILMJS LLC (SPV) to earn additional Pubco Class A Common Stock based on performance targets.
• B. Luke Weil, the company's CEO, will receive 336,000 shares of Pubco Class A Common Stock, subject to vesting, for providing consulting services to Pubco post-closing.

Stakeholder Impact

• Shareholders: Face potential dilution from Founder Shares' anti-dilution rights and Private Placement Warrants. Public shareholders have redemption rights, but these can reduce funds for the Business Combination. The 'going concern' doubt poses a significant risk to their investment.
• Management: Has significant incentives (Founder Shares, earnout shares, consulting agreement for CEO) tied to the successful completion of the Business Combination. Potential conflicts of interest exist due to other business obligations.
• Underwriters (BTIG, Craig-Hallum): Are entitled to a deferred fee upon Business Combination completion, creating an incentive for the deal to close. Craig-Hallum also secured future financing participation rights.
• Boost Run Sellers: Will receive a significant portion of the consideration in Pubco Common Stock and earnout shares, aligning their interests with the post-merger company's performance.
• Creditors: The Trust Account is generally protected from creditor claims, but there's a risk if waivers are not obtained or if the company liquidates with insufficient funds outside the Trust Account.

Next Steps

• Complete the Boost Run Business Combination by the extended deadline of June 30, 2026.
• File the Boost Run Registration Statement (Form S-4) with the SEC and work to cause it to become effective.
• Obtain shareholder approval for the Boost Run BCA and related matters at an extraordinary general meeting.
• Call a meeting of Boost Run members to obtain the requisite approval for the Business Combination.
• Potentially seek additional financing to complete the Business Combination or fund the post-combination company's operations.
• B. Luke Weil will commence providing consulting services to Pubco following the Closing, for which he will receive Pubco Class A Common Stock.

Key Dates

Recommendation

The filing presents a mixed bag for investors. While the company has identified a target and is progressing towards a Business Combination, the explicit 'going concern' doubt and the extension of the merger deadline introduce significant uncertainty. The potential for substantial dilution and the mixed track record of management's prior SPACs warrant caution. However, the significant cash in the Trust Account and the potential for a successful merger with Boost Run prevent a 'sell' recommendation. Investors should hold and closely monitor the progress of the Boost Run Business Combination and the company's liquidity position.

Keywords

SPAC, Business Combination, Boost Run, Merger, 10-K, SEC Filing, Going Concern, Liquidity, Warrants, Shareholder Redemption, Dilution, Nasdaq, Corporate Governance, Financial Performance, Investment